Literature DB >> 11595286

Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons.

S C Schmechel1, N Russell, F Hladik, J Lang, A Wilson, R Ha, A Desbien, M J McElrath.   

Abstract

Rare individuals who are repeatedly exposed to HIV-1 through unprotected sexual contact fail to acquire HIV-1 infection. These persons represent a unique study population to evaluate mechanisms by which HIV-1 replication is either prevented or controlled. We followed longitudinally a group of healthy HIV-1 seronegative persons each reporting repeated high-risk sexual activities with their HIV-1-infected partner at enrollment. The volunteers were primarily (90%) male homosexuals, maintaining high risk activities with their known infected partner (45%) or multiple other partners (61%). We evaluated the quantity and specificity of HIV-1-specific T cells in 31 exposed seronegatives (ES) using a IFN-gamma ELISPOT assay to enumerate T cells recognizing epitopes within HIV-1 Env, Gag, Pol and Nef. PBMC from only three of the 31 volunteers demonstrated ex vivo HIV-1-specific IFN-gamma secretion, in contrast to nearly 30% exhibiting cytolytic responses in previous studies. These findings suggest that if T cell responses in ES are induced by HIV-1 exposure, the frequency is at low levels in most of them, and below the level of detection using the ELISPOT assay. Alternative approaches to improve the sensitivity of detection may include use of dendritic cells as antigen-presenting cells in the ex vivo assay and more careful definition of the risk behavior and extent of HIV-1 exposure in conjunction with the evaluation of T cell responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595286     DOI: 10.1016/s0165-2478(01)00262-0

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  10 in total

1.  Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection.

Authors:  Laura Pattacini; Jared M Baeten; Katherine K Thomas; Tayler R Fluharty; Pamela M Murnane; Deborah Donnell; Elizabeth Bukusi; Allan Ronald; Nelly Mugo; Jairam R Lingappa; Connie Celum; M Juliana McElrath; Jennifer M Lund
Journal:  J Acquir Immune Defic Syndr       Date:  2016-06-01       Impact factor: 3.731

Review 2.  Non-human primate models for AIDS vaccine research.

Authors:  Shiu-Lok Hu
Journal:  Curr Drug Targets Infect Disord       Date:  2005-06

3.  A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations.

Authors:  Zhong-Min Ma; Kristina Abel; Tracy Rourke; Yichuan Wang; Christopher J Miller
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners.

Authors:  Yi Liu; Amanda Woodward; Haiying Zhu; Thomas Andrus; John McNevin; Jean Lee; James I Mullins; Lawrence Corey; M Juliana McElrath; Tuofu Zhu
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

5.  HV-1-specific cytotoxic T lymphocytes and breast milk HIV-1 transmission.

Authors:  Grace C John-Stewart; Dorothy Mbori-Ngacha; Barbara Lohman Payne; Carey Farquhar; Barbra A Richardson; Sandra Emery; Phelgona Otieno; Elizabeth Obimbo; Tao Dong; Jennifer Slyker; Ruth Nduati; Julie Overbaugh; Sarah Rowland-Jones
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

6.  Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed individuals who remain uninfected.

Authors:  Marta Ruiz-Riol; Anuska Llano; Javier Ibarrondo; Jennifer Zamarreño; Karina Yusim; Vanessa Bach; Beatriz Mothe; Susana Perez-Alvarez; Marco A Fernandez; Gerard Requena; Michael Meulbroek; Ferran Pujol; Agathe Leon; Patricia Cobarsi; Bette T Korber; Bonaventura Clotet; Carmela Ganoza; Jorge Sanchez; Josep Coll; Christian Brander
Journal:  J Infect Dis       Date:  2014-09-23       Impact factor: 5.226

7.  Impaired viral entry cannot explain reduced CD4+ T cell susceptibility to HIV type 1 in certain highly exposed individuals.

Authors:  Emily C Speelmon; Devon Livingston-Rosanoff; Anthony L Desbien; Jean Lee; W David Wick; Florian Hladik; M Juliana McElrath
Journal:  AIDS Res Hum Retroviruses       Date:  2008-11       Impact factor: 2.205

8.  Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals.

Authors:  Adam J Ritchie; Suzanne L Campion; Jakub Kopycinski; Zoe Moodie; Z Maggie Wang; Kruti Pandya; Stephen Moore; Michael K P Liu; Simon Brackenridge; Kristin Kuldanek; Kenneth Legg; Myron S Cohen; Eric L Delwart; Barton F Haynes; Sarah Fidler; Andrew J McMichael; Nilu Goonetilleke
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

9.  Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats.

Authors:  Kristina E Howard; Stacie K Reckling; Erin A Egan; Gregg A Dean
Journal:  Retrovirology       Date:  2010-01-19       Impact factor: 4.602

10.  Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes.

Authors:  Otto O Yang; Phuong Thi Nguyen Sarkis; Ayub Ali; Jason D Harlow; Christian Brander; Spyros A Kalams; Bruce D Walker
Journal:  J Exp Med       Date:  2003-05-12       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.